variety of broad-spectrum single-agent and combination regimens have been highly successful when given to women hospitalized for treatment of acute pelvic inflammatory disease (PID).
The optimal antibiotic regimen for inpatient therapy of such women has not been established. The etiology of this acute pelvic infection is generally thought to involve Neisseria gonorrhoeae, Chlamydia trachomatis, and a wide variety of anaerobic and aerobic bacteria. Treatment regimens must include broad-spectrum coverage of these likely pathogens. Additionally, therapy must be effective in the various forms and complications of PID (e.g., endometritis, salpingitis, and pelvic inflammatory mass/ abscess). Combination 
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Intrauterine device N. gonorrhoeae continues to be the sexually transmitted disease species most frequently recovered from women admitted to our hospital for parenteral therapy. Although the percentage of women admitted for inpatient therapy who had N. gonorrhoeae has remained relatively constant at between 50 and 60% over the past 7 years (data not shown), the number of women admitted has decreased almost 70% from 226 in 1985 to only 60 in 1992. We found that the broad-spectrum antimicrobial regimen of ampicillin/sulbactam given 3g IV every 6 h was clinically superior to cefoxitin 2 g IV every 6 h in the treatment of women with acute PID diagnosed in an emergency room. On subgroup analyses, the efficacy of the 2 
